Author Archives : Editorial Team

Home  >>  Author : Editorial Team

Julia Schaft appointed new Managing Director at BioRN

On October 22, 2018, Posted by , In Press Releases, With Comments Off on Julia Schaft appointed new Managing Director at BioRN

Heidelberg, 22.10.2018 Effective September 30, 2018, Fritz Richter retired from his roles as Managing Director of the BioRN Network e.V. and the BioRN Cluster Management GmbH, although he will stay actively connected to the organization. We are pleased to announce that the boards of BioRN Network e.V. and BioRN Cluster…

DKFZ: Takeda Oncology Research Award 2018 to Rocio Sotillo

On October 19, 2018, Posted by , In News, By ,, , With Comments Off on DKFZ: Takeda Oncology Research Award 2018 to Rocio Sotillo

A certain form of lung cancer is characterized by two genes that are accidentally fused. The fusion produces a growth signal for the cells. These tumors respond well to a targeted drug that deprives the cancer cells of the growth stimulus. Several molecular variants of cancer-promoting gene fusion exist. Rocio…

Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

On October 15, 2018, Posted by , In News, By , , With Comments Off on Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

Ready-to-use kits determine genomic characteristics of solid tumours Optimized workflow to generate results in house Software analysis allows correlation to AVENIO ctDNA NGS kits Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global commercial launch of three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits – the AVENIO…

BioRN Lounge: Heike A. Wieland reported on a freshly established research collaboration in Heidelberg.

On October 10, 2018, Posted by , In Press Releases, By , With Comments Off on BioRN Lounge: Heike A. Wieland reported on a freshly established research collaboration in Heidelberg.

Heidelberg, 10.10.2018 After the long summer break, the BioRN Lounge was the occasion for life science companies as well for scientists from our research institutes, to meet and chat about latest news and achievements. The BioRN Lounge is the prime monthly networking event for BioRN members. It is the occasion…

DKFZ: Machine Learning to Accellerate Drug Research

On October 10, 2018, Posted by , In News, By , , With Comments Off on DKFZ: Machine Learning to Accellerate Drug Research

The European Research Council (ERC) is awarding a “proof-of-concept grant” to scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Heidelberg University for the first time to enable them to develop new drugs more cheaply and quickly using image-based analyses. Automated microscopy documents changes in cells after…

Jörg Debatin to chair the supervisory board of Hummingbird Diagnostics GmbH

On October 9, 2018, Posted by , In News, With Comments Off on Jörg Debatin to chair the supervisory board of Hummingbird Diagnostics GmbH

International healthcare leader strengthens miRNA experts Hummingbird Diagnostics GmbH announced that Prof. Dr. med. Jörg Debatin is appointed Chairman of the Supervisory Board with immediate effect. The former Vice President and Chief Technology Officer of GE Healthcare and CEO of Amedes AG directed the University Hospital Hamburg-Eppendorf for 8 years…

Heidelberg University: Highly Organised Process: How Protein Complexes Form in the Cell

On October 8, 2018, Posted by , In News, By , With Comments Off on Heidelberg University: Highly Organised Process: How Protein Complexes Form in the Cell

Heidelberg researchers gain fundamental new insights into synthesis of biologically active complexes. The formation of protein complexes is a highly organised process that does not begin with the “finished” proteins. Studies conducted by researchers at the Center for Molecular Biology of Heidelberg University (ZMBH) and the German Cancer Research Center…

Breast cancer: Towards individualized therapy

On October 8, 2018, Posted by , In News, By , , With Comments Off on Breast cancer: Towards individualized therapy

Breast cancer is as manifold as are those who are affected. Therefore, scientists and physicians from the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD) and the National Center for Tumor Diseases (NCT) in Heidelberg are generating genetic profiles from metastatic tissue samples before they choose, on this basis,…

Preclinical Efficacy Data of Apogenix’ HERA – CD27L Published in Frontiers in Oncology

On October 4, 2018, Posted by , In News, By , With Comments Off on Preclinical Efficacy Data of Apogenix’ HERA – CD27L Published in Frontiers in Oncology

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that new data published in the current volume of Frontiers in Oncology demonstrate the potent anti – tumor efficacy of Apogenix’ HERA – CD27L. In contrast to antibodies in development, HERA – CD27L is the first true CD27 receptor…

Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

On October 4, 2018, Posted by , In Press Releases, By , , With Comments Off on Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

Heidelberg, 04.10.2018 On Tuesday October 2, Guenter Huhle, Head of JLABS EMEA, Johnson & Johnson Innovation shared key insights on the art of pitching in front of a packed audience of researchers, entrepreneurs and professionals mainly from the Heidelberg area.   Panel discussion: Maciek Drozdz (Principal of Venture Investments for…